Adial Pharmaceuticals's total assets for Q4 2025 were $6.80M, an increase of 20.12% from the previous quarter. ADIL total liabilities were $1.52M for the fiscal quarter, a 31.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.